Novo Holdings A/S’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,000,000
| Closed | -$13.7M | – | 33 |
|
|
2025
Q1 | $13.7M | Buy |
3,000,000
+600,000
| +25% | +$2.74M | 1.04% | 22 |
|
|
2024
Q4 | $13.5M | Hold |
2,400,000
| – | – | 0.82% | 24 |
|
|
2024
Q3 | $11.6M | Hold |
2,400,000
| – | – | 0.58% | 29 |
|
|
2024
Q2 | $11.7M | Buy |
2,400,000
+400,000
| +20% | +$1.95M | 0.63% | 32 |
|
|
2024
Q1 | $26.6M | Hold |
2,000,000
| – | – | 1.83% | 21 |
|
|
2023
Q4 | $27.9M | Buy |
+2,000,000
| New | +$27.9M | 1.72% | 23 |
|
|
2023
Q3 | – | Sell |
-500,000
| Closed | -$9.38M | – | 41 |
|
|
2023
Q2 | $9.38M | Sell |
500,000
-700,000
| -58% | -$13.1M | 0.72% | 32 |
|
|
2023
Q1 | $17.3M | Buy |
1,200,000
+288,889
| +32% | +$4.17M | 1.14% | 26 |
|
|
2022
Q4 | $17.6M | Hold |
911,111
| – | – | 1.1% | 23 |
|
|
2022
Q3 | $31.3M | Sell |
911,111
-15,989
| -2% | -$549K | 1.49% | 17 |
|
|
2022
Q2 | $14.2M | Buy |
927,100
+177,100
| +24% | +$2.71M | 0.7% | 28 |
|
|
2022
Q1 | $17.1M | Buy |
750,000
+50,000
| +7% | +$1.14M | 0.9% | 20 |
|
|
2021
Q4 | $25.8M | Buy |
700,000
+100,000
| +17% | +$3.69M | 1.22% | 17 |
|
|
2021
Q3 | $28.2M | Sell |
600,000
-193,265
| -24% | -$9.08M | 1.46% | 15 |
|
|
2021
Q2 | $47.8M | Buy |
+793,265
| New | +$47.8M | 2.12% | 14 |
|